NCT04464447

Brief Summary

Recurrent and impairing functional somatic syndromes (FSS) are common in adolescents. Despite a high need for care, empirically supported treatments are lacking for youth. The aim of the uncontrolled was to assess feasibility and treatment potential of group-based Acceptance and Commitment Therapy (ACT) in a generic treatment approach for adolescents with multiple FSS i.e. "ACT for Health in Adolescents" (AHEAD).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2013

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2013

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2015

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2015

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

June 27, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 9, 2020

Completed
Last Updated

June 14, 2021

Status Verified

June 1, 2020

Enrollment Period

1.9 years

First QC Date

June 27, 2020

Last Update Submit

June 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Short Form Health Survey-36 (SF36) (Assessment of an aggregate score measuring physical health)

    Questionnaire, patient rated. Physical health measured with aggregate scores of the scales PF (physical functioning), BP (bodily pain) and VT (vitality). Score range 15-65. Higher scores indicating a higher degree of self-rated physical health.

    At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)

Secondary Outcomes (10)

  • Change in Bodily Distress Syndrome checklist (BDS checklist)

    At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)

  • Change in Limitation index Questionnaire

    At baseline (i.e. at clinical assessment), before psychiatric consultation (approximately 2 weeks after clinical assessment), and at 2, 3, 4, 5, and 8 months (corresponding to before therapy, after 4th, 8th, 9th module and at follow up meeting)

  • Change in Whiteley 7

    At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)

  • Change in SCL-8 Questionnaire

    At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)

  • Change in SF-36 PCS

    At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)

  • +5 more secondary outcomes

Other Outcomes (2)

  • Modified version of ESQ Experience of Service Questionnaire

    At 8 months corresponding to at follow up meeting

  • Questions concerning close relatives' satisfaction with information meeting

    At meeting for close relatives corresponding to approximately 1 week after start of group therapy (i.e. at 2 months)

Study Arms (1)

Group-based Acceptance and Commitment Therapy

OTHER

Group-based Acceptance and Commitment Therapy (ACT) for adolescents presenting with multiple functional somatic syndromes.

Behavioral: Acceptance and Commitment Therapy

Interventions

The treatment "ACT for Health in Adolescents" (AHEAD) is an ACT-based Group intervention consisting of 9 modules (27 hours in total) delivered over a period of 3 months, with a follow-up meeting (3 hours) 3 months after the last module. Six to eight patients participate in each treatment Group. An information meeting (3 hours) for close relatives is held at the beginning of the Group treatment and the adolescents and their parents were invited to a 1½-hour individual consultation after the 8th module.

Group-based Acceptance and Commitment Therapy

Eligibility Criteria

Age15 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Bodily Distress Syndrome, multi-organ type of at least 12 months' duration
  • Raised since early childhood in Denmark or born by Danish parents
  • Understand, speak and read Danish
  • Moderate or severe impairment

You may not qualify if:

  • Acute psychiatric disorder demanding other treatment, or if the patient is suicidal.
  • A lifetime diagnosis of psychosis, mania or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.2, F33.3), serious cognitive deficits or developmental disorders such as mental retardation and autism (ICD-10: F70, F84)
  • Substance abuse of e.g. narcotics, alcohol or medication.
  • Not able to participate in group-based treatment, e.g. patients with severe ADHD (ICD-10: F90), severe social phobia (ICD-10: F40.1) or conduct disorder (ICD-10: F91)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kallesoe KH, Schroder A, Wicksell RK, Preuss T, Jensen JS, Rask CU. Feasibility of group-based acceptance and commitment therapy for adolescents (AHEAD) with multiple functional somatic syndromes: a pilot study. BMC Psychiatry. 2020 Sep 21;20(1):457. doi: 10.1186/s12888-020-02862-z.

MeSH Terms

Interventions

Acceptance and Commitment Therapy

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Charlotte U Rask, MD, PhD

    Aarhus University and during study the Research Clinic for Functional Disorders and Psychosomatics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2020

First Posted

July 9, 2020

Study Start

May 29, 2013

Primary Completion

April 15, 2015

Study Completion

April 24, 2015

Last Updated

June 14, 2021

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Has not been incorporated in the consent from the patients. However, some data will be available upon request.